GF422

IL-17F, Human

HumanKine^®, recombinant, Xeno-free, >95% (SDS-PAGE), suitable for cell culture

• Codice UNSPSC: 12352202
• eCl@ss: 32160405
• NACRES: NA.75

Proprietà

• product name: HumanKine^® IL-17F, Human Recombinant Xeno-Free,
• Saggio: >95% (SDS-PAGE)
• Livello qualitativo: 300
• Caratteristiche: endotoxin free
• N° accesso UniProt: Q16552

Descrizione

Descrizione generale

HumanKine growth factors are expressed in a proprietary human 293 protein expression system and are manufactured without the use of any animal products and are considered Xeno-Free.

Interleukin-17F (IL-17F) is is a cytokine that shares sequence similarity with IL17. This cytokine is expressed by activated T cells, and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM-CSF. This cytokine is also found to inhibit the angiogenesis of endothelial cells and induce endothelial cells to produce IL2, TGFB1/TGFB, and monocyte chemoattractant protein-1.

Qualità

Bioactivity assay: Determined by the dose-dependent induction of IL-6 secretion from NDHF Adult fibroblasts. ED50 is typically 100-500 ng/ml.

HumanKine IL-17F is manufactured using all non-animal reagents and is considered Xeno-Free

Stato fisico

Product is presented in PBS and filtered through a 0.2 micron filter before lyophilization.

Stoccaggio e stabilità

Store at -20°C for up to 4 months from date of receipt. Further dilutions should be made into appropriate buffer or medium to which protein has been added.

Note legali

HumanKine is a registered trademark of Proteintech Group, Inc. and Humanzyme, Inc

Esclusione di responsabilità

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.